Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2008-10-8
pubmed:abstractText
The aim of this study was to develop a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1432-1335
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
134
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1199-206
pubmed:dateRevised
2009-3-17
pubmed:meshHeading
pubmed-meshheading:18528707-Adult, pubmed-meshheading:18528707-Aged, pubmed-meshheading:18528707-Antigens, Tumor-Associated, Carbohydrate, pubmed-meshheading:18528707-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18528707-Area Under Curve, pubmed-meshheading:18528707-Breast Neoplasms, pubmed-meshheading:18528707-Carcinoembryonic Antigen, pubmed-meshheading:18528707-Female, pubmed-meshheading:18528707-Humans, pubmed-meshheading:18528707-Menopause, pubmed-meshheading:18528707-Middle Aged, pubmed-meshheading:18528707-Mucin-1, pubmed-meshheading:18528707-Neoplasm Metastasis, pubmed-meshheading:18528707-Neoplasm Recurrence, Local, pubmed-meshheading:18528707-Predictive Value of Tests, pubmed-meshheading:18528707-Premenopause, pubmed-meshheading:18528707-Tumor Markers, Biological
pubmed:year
2008
pubmed:articleTitle
Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer.
pubmed:affiliation
Breast and Medical Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. kyonemor@ncc.go.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III